Skeletal muscle proteomic signature and metabolic impairment in pulmonary hypertension

Journal of Molecular Medicine

Volumn 93, Issue 5, 2015, Pages 573-584

  Malenfant, Simon ^a   Potus, François ^a   Fournier, Frédéric ^b   Breuils Bonnet, Sandra ^a   Pflieger, Aude ^a   Bourassa, Sylvie ^b   Tremblay, Ève ^a   Nehmé, Benjamin ^b   Droit, Arnaud ^b   Bonnet, Sébastien ^a   Provencher, Steeve ^a  

^a LAVAL UNIVERSITY   (Canada)

^b University Laval   (Canada)

Author keywords

Exercise capacity; Mitochondrial metabolism; Proteomic; Pulmonary hypertension; Skeletal muscle

Indexed keywords

PROTEOME;

ADULT; BIOPSY; CLUSTER ANALYSIS; EXERCISE TOLERANCE; FEMALE; HUMAN; MALE; METABOLISM; METABOLOMICS; MIDDLE AGED; MITOCHONDRION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; PROTEOMICS; PULMONARY HYPERTENSION; SKELETAL MUSCLE;

ADULT; BIOPSY; CLUSTER ANALYSIS; EXERCISE TOLERANCE; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; METABOLIC NETWORKS AND PATHWAYS; METABOLOMICS; MIDDLE AGED; MITOCHONDRIA; MUSCLE, SKELETAL; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEOME; PROTEOMICS;

EID: 84939985811     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-014-1244-0     Document Type: Article

References (57)

1. Hoeper MM, Bogaard HJ, Condliffe R, Frantz R, Khanna D, Kurzyna M, Langleben D, Manes A, Satoh T, Torres F et al (2013) Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol 62:D42–D50
2. Mainguy V, Provencher S, Maltais F, Malenfant S, Saey D (2011) Assessment of daily life physical activities in pulmonary arterial hypertension. PLoS One 6:e27993
3. Rival G, Lacasse Y, Martin S, Bonnet S, Provencher S (2014) Effect of pulmonary arterial hypertension specific therapies on health-related quality of life: a systematic review. Chest 146:686–708
4. Pugh ME, Buchowski MS, Robbins IM, Newman JH, Hemnes AR (2012) Physical activity limitation as measured by accelerometry in pulmonary arterial hypertension. Chest 142:1391–1398
5. Mainguy V, Maltais F, Saey D, Gagnon P, Martel S, Simon M, Provencher S (2010) Peripheral muscle dysfunction in idiopathic pulmonary arterial hypertension. Thorax 65:113–117
6. Potus F, Malenfant S, Graydon C, Mainguy V, Tremblay E, Breuils-Bonnet S, Ribeiro F, Porlier A, Maltais F, Bonnet S et al (2014) Impaired angiogenesis and peripheral muscle microcirculation loss contribute to exercise intolerance in pulmonary arterial hypertension. Am J Respir Crit Care Med 190:318–328
7. Sutendra G, Michelakis ED (2014) The metabolic basis of pulmonary arterial hypertension. Cell Metab 19:558–573
8. Courboulin A, Paulin R, Giguère NJ, Saksouk N, Perreault T, Meloche J, Paquet ER, Biardel S, Provencher S, Côté J et al (2011) Role for miR-204 in human pulmonary arterial hypertension. J Exp Med 208:535–548
9. Dromparis P, Paulin R, Stenson TH, Haromy A, Sutendra G, Michelakis ED (2013) Attenuating endoplasmic reticulum stress as a novel therapeutic strategy in pulmonary hypertension. Circulation 127:115–125
10. Paulin R, Dromparis P, Sutendra G, Gurtu V, Zervopoulos S, Bowers L, Haromy A, Webster L, Provencher S, Bonnet S et al (2014) Sirtuin 3 deficiency is associated with inhibited mitochondrial function and pulmonary arterial hypertension in rodents and humans. Cell Metab 20:827–839
11. Piao L, Fang Y-H, Cadete VJJ, Wietholt C, Urboniene D, Toth PT, Marsboom G, Zhang HJ, Haber I, Rehman J et al (2010) The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle. J Mol Med 88:47–60
12. Sutendra G, Dromparis P, Paulin R, Zervopoulos S, Haromy A, Nagendran J, Michelakis ED (2013) A metabolic remodeling in right ventricular hypertrophy is associated with decreased angiogenesis and a transition from a compensated to a decompensated state in pulmonary hypertension. J Mol Med 91:1315–1327
13. Enache I, Charles AL, Bouitbir J, Favret F, Zoll J, Metzger D, Oswald-Mammosser M, Geny B, Charloux A (2013) Skeletal muscle mitochondrial dysfunction precedes right ventricular impairment in experimental pulmonary hypertension. Mol Cell Biochem 373:161–170
14. Mabuchi K, Sréter FA (1980) Actomyosin ATPase. II. Fiber typing by histochemical ATPase reaction. Muscle Nerve 3:233–239
15. Larsen S, Nielsen J, Hansen CN, Nielsen LB, Wibrand F, Stride N, Schroder HD, Boushel R, Helge JW, Dela F et al (2012) Biomarkers of mitochondrial content in skeletal muscle of healthy young human subjects. J Physiol (Lond) 590:3349–3360
16. Zeeberg BR, Feng W, Wang G, Wang MD, Fojo AT, Sunshine M, Narasimhan S, Kane DW, Reinhold WC, Lababidi S et al (2003) GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol 4:R28
17. Maere S, Heymans K, Kuiper M (2005) BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 21:3448–3449
18. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13:2498–2504
19. Bonnet S, Michelakis ED, Porter C, Andrade-Navarro M, Thebaud B, Breuils-Bonnet S, Haromy A, Harry G, Moudgil R, McMurtry S et al (2006) An abnormal mitochondrial-hypoxia inducible factor-1 alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats—similarities to human pulmonary arterial hypertension. Circulation 113:2630–2641
20. Archer SL (2013) Mitochondrial dynamics—mitochondrial fission and fusion in human diseases. N Engl J Med 369:2236–2251
21. Ryan JJ, Marsboom G, Fang Y-H, Toth PT, Morrow E, Luo N, Piao L, Hong Z, Ericson K, Zhang HJ et al (2013) PGC1α-mediated mitofusin-2 deficiency in female rats and humans with pulmonary arterial hypertension. Am J Respir Crit Care Med 187:865–878
22. Ullrich M, Liang V, Chew YL, Banister S, Song X, Zaw T, Lam H, Berber S, Kassiou M, Nicholas HR et al (2014) Bio-orthogonal labeling as a tool to visualize and identify newly synthesized proteins in Caenorhabditis elegans. Nat Protoc 9:2237–2255
23. 18 F-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of pulmonary arterial hypertension. Am J Respir Crit Care Med 185:670–679
24. Piao L, Fang Y-H, Parikh K, Ryan JJ, Toth PT, Archer SL (2013) Cardiac glutaminolysis: a maladaptive cancer metabolism pathway in the right ventricle in pulmonary hypertension. J Mol Med 91:1185–1197
25. Rogers MA, Hagberg JM, Martin WH, Ehsani AA, Holloszy JO (1990) Decline in VO2max with aging in master athletes and sedentary men. J Appl Physiol 68:2195–2199
26. Chance B, Leigh JS, Clark BJ, Maris J, Kent J, Nioka S, Smith D (1985) Control of oxidative metabolism and oxygen delivery in human skeletal muscle: a steady-state analysis of the work/energy cost transfer function. Proc Natl Acad Sci U S A 82:8384–8388
27. Provencher S, Chemla D, Hervé P, Sitbon O, Humbert M, Simonneau G (2006) Heart rate responses during the 6-minute walk test in pulmonary arterial hypertension. Eur Respir J 27:114–120
28. Groepenhoff H, Holverda S, Marcus JT, Postmus PE, Boonstra A, Vonk-Noordegraaf A (2007) Stroke volume response during exercise measured by acetylene uptake and MRI. Physiol Meas 28:1–11
29. Tolle J, Waxman A, Systrom D (2008) Impaired systemic oxygen extraction at maximum exercise in pulmonary hypertension. Med Sci Sports Exerc 40:3–8
30. De Bock K, Georgiadou M, Carmeliet P (2013) Role of endothelial cell metabolism in vessel sprouting. Cell Metab 18:634–647
31. Tomasetti M, Nocchi L, Staffolani S, Manzella N, Amati M, Goodwin J, Kluckova K, Nguyen M, Strafella E, Bajzikova M et al (2014) MicroRNA-126 suppresses mesothelioma malignancy by targeting IRS1 and interfering with the mitochondrial function. Antioxid Redox Signal 21:2109–2125
32. Abdul-Salam VB, Paul GA, Ali JO, Gibbs SR, Rahman D, Taylor GW, Wilkins MR, Edwards RJ (2006) Identification of plasma protein biomarkers associated with idiopathic pulmonary arterial hypertension. Proteomics 6:2286–2294
33. Abdul-Salam VB, Wharton J, Cupitt J, Berryman M, Edwards RJ, Wilkins MR (2010) Proteomic analysis of lung tissues from patients with pulmonary arterial hypertension. Circulation 122:2058–2067
34. Paulin R, Michelakis ED (2014) The metabolic theory of pulmonary arterial hypertension. Circ Res 115:148–164
35. Ryan JJ, Archer SL (2014) The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure. Circ Res 115:176–188
36. Humbert M, Monti G, Brenot F, Sitbon O, Portier A, Grangeot-Keros L, Duroux P, Galanaud P, Simonneau G, Emilie D (1995) Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit Care Med 151:1628–1631
37. Bertero T, Lu Y, Annis S, Hale A, Bhat B, Saggar R, Saggar R, Wallace WD, Ross DJ, Vargas SO et al (2014) Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertension. J Clin Invest 124:3514–3528
38. Rabinovitch M (2010) PPARgamma and the pathobiology of pulmonary arterial hypertension. Adv Exp Med Biol 661:447–458
39. Kintscher U, Law RE (2005) PPARgamma-mediated insulin sensitization: the importance of fat versus muscle. Am J Physiol Endocrinol Metab 288:E287–E291
40. Hansmann G, Wagner RA, Schellong S, Perez VAJ, Urashima T, Wang L, Sheikh AY, Suen RS, Stewart DJ, Rabinovitch M (2007) Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation. Circulation 115:1275–1284
41. Zamanian RT, Hansmann G, Snook S, Lilienfeld D, Rappaport KM, Reaven GM, Rabinovitch M, Doyle RL (2009) Insulin resistance in pulmonary arterial hypertension. Eur Respir J 33:318–324
42. West J, Niswender KD, Johnson JA, Pugh ME, Gleaves L, Fessel JP, Hemnes AR (2013) A potential role for insulin resistance in experimental pulmonary hypertension. Eur Respir J 41:861–871
43. Aguer C, Mercier J, Man CYW, Metz L, Bordenave S, Lambert K, Jean E, Lantier L, Bounoua L, Brun JF et al (2010) Intramyocellular lipid accumulation is associated with permanent relocation ex vivo and in vitro of fatty acid translocase (FAT)/CD36 in obese patients. Diabetologia 53:1151–1163
44. Karakelides H, Asmann YW, Bigelow ML, Short KR, Dhatariya K, Coenen-Schimke J, Kahl J, Mukhopadhyay D, Nair KS (2007) Effect of insulin deprivation on muscle mitochondrial ATP production and gene transcript levels in type 1 diabetic subjects. Diabetes 56:2683–2689
45. Cheng Z, Almeida FA (2014) Mitochondrial alteration in type 2 diabetes and obesity: an epigenetic link. Cell Cycle 13:890–897
46. Sousa Silva M, Gomes RA, Ferreira AEN, Ponces Freire A, Cordeiro C (2013) The glyoxalase pathway: the first hundred years… and beyond. Biochem J 453:1–15
47. Khajali F, Liyanage R, Wideman RF (2011) Methylglyoxal and pulmonary hypertension in broiler chickens. Poult Sci 90:1287–1294
48. Meloche J, Pflieger A, Vaillancourt M, Paulin R, Potus F, Zervopoulos S, Graydon C, Courboulin A, Breuils-Bonnet S, Tremblay E et al (2014) Role for DNA damage signaling in pulmonary arterial hypertension. Circulation 129:786–797
49. Malenfant S, Neyron A-S, Paulin R, Potus F, Meloche J, Provencher S, Bonnet S (2013) Signal transduction in the development of pulmonary arterial hypertension. Pulm Circ 3:278–293
50. Maltais F, Decramer M, Casaburi R, Barreiro E, Burelle Y, Debigaré R, Dekhuijzen PNR, Franssen F, Gayan-Ramirez G, Gea J et al (2014) An official american thoracic society/european respiratory society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 189:e15–e62
51. Allaire J, Maltais F, Doyon J-F, Noël M, Leblanc P, Carrier G, Simard C, Jobin J (2004) Peripheral muscle endurance and the oxidative profile of the quadriceps in patients with COPD. Thorax 59:673–678
52. Maltais F, Simard AA, Simard C, Jobin J, Desgagnés P, LeBlanc P (1996) Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med 153:288–293
53. Maltais F, Leblanc P, Whittom F, Simard C, Marquis K, Bélanger M, Breton MJ, Jobin J (2000) Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD. Thorax 55:848–853
54. Meyer A, Zoll J, Charles A-L, Charloux A, de Blay F, Diemunsch P, Sibilia J, Piquard F, Geny B (2013) Skeletal muscle mitochondrial dysfunction during chronic obstructive pulmonary disease: central actor and therapeutic target. Exp Physiol 98:1063–1078
55. Mainguy V, Maltais F, Saey D, Gagnon P, Martel S, Simon M, Provencher S (2010) Effects of a rehabilitation program on skeletal muscle function in idiopathic pulmonary arterial hypertension. J Cardiopulm Rehabil Prev 30:319–323
56. de Man FS, Handoko ML, Groepenhoff H, van t Hul AJ, Abbink J, Koppers RJH, Grotjohan HP, Twisk JWR, Bogaard H-J, Boonstra A et al (2009) Effects of exercise training in patients with idiopathic pulmonary arterial hypertension. Eur Respir J 34:669–675
57. Batt J, Shadly Ahmed S, Correa J, Bain A, Granton J (2014) Skeletal muscle dysfunction in idiopathic pulmonary arterial hypertension. Am J Respir Cell Mol Biol 50:74–86